Safety and Efficacy of Tralokinumab in Older Adults With Moderate-to-Severe Atopic Dermatitis: A Secondary Analysis. - Merola JF; Butler DC; Mark T; Schneider S; Kim Y; Abuabara K (JAMA dermatology, 2023)